These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 410164

  • 21. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
    Duchon J, Matous B, Pavel S.
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):139-44. PubMed ID: 97931
    [Abstract] [Full Text] [Related]

  • 22. Inability to demonstrate hydroxylation of tyrosine by murine melanoma "tyrosinase" (L-DOPA oxidase), using the tritiated water assay technique.
    Shapiro HC, Edelstein LM, Patel RP, Okun MR, Blackburn M, Snyder M, Brennan T, Wilgram G.
    J Invest Dermatol; 1979 Apr; 72(4):191-3. PubMed ID: 107247
    [Abstract] [Full Text] [Related]

  • 23. The effect of polyamines on tyrosinase activity.
    Galindo JD, Martinez JH, Lopez-Ballester JA, Peñafiel R, Solano F, Lozano JA.
    Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
    [Abstract] [Full Text] [Related]

  • 24. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
    Dernałowicz-Malarczyk E, Kotłowska-Niećko I.
    Neoplasma; 1980 Dec; 27(4):345-53. PubMed ID: 6779209
    [Abstract] [Full Text] [Related]

  • 25. [Histochemical phenoloxidase demonstration in tumors of the melanocytic system].
    Schmidt H, Wagner U.
    Acta Histochem; 1986 Dec; 79(1):23-31. PubMed ID: 3090836
    [Abstract] [Full Text] [Related]

  • 26. The hydroxyl radical is not involved with tyrosinase inactivation.
    Tomita Y, Seiji M, Igarashi A.
    J Dermatol; 1980 Oct; 7(5):377-80. PubMed ID: 6782145
    [No Abstract] [Full Text] [Related]

  • 27. [Investigation of tyrosinase activity and phospholipid composition in Harding-Passey melanoma microsomal fraction].
    Shtol'ko VN, Bogdanov GN, Vasil'eva LS, Burlakova EB.
    Biokhimiia; 1978 Jan; 43(1):121-6. PubMed ID: 414789
    [Abstract] [Full Text] [Related]

  • 28. NIH peer review favoritism: lavish financial support for questionable old concept of mammalian melanogenesis; absence of support for work based on new concept.
    Okun MR, Edelstein LM, Patel RP.
    Physiol Chem Phys; 1976 Jan; 8(2):177-86. PubMed ID: 824659
    [No Abstract] [Full Text] [Related]

  • 29. Inability of murine melanoma "tyrosinase" (dopa ozidase) to oxidize tyrosine in the presence or absence of dopa or dihydroxyfumarate cofactor.
    Patel RP, Okun MR, Yee WA, Wilgram GF, Edelstein LM.
    J Invest Dermatol; 1973 Aug; 61(2):55-9. PubMed ID: 4199461
    [No Abstract] [Full Text] [Related]

  • 30. In vitro effects of melanocytolytic agents and other compounds upon dominant human melanoma tyrosinase activity.
    Chen YM, Chavin W.
    Experientia; 1978 Jan 15; 34(1):21-2. PubMed ID: 413735
    [Abstract] [Full Text] [Related]

  • 31. In vitro effects of hormonal stimuli upon tyrosinase and peroxidase activities in murine melanomas.
    Abramowitz J, Chavin W.
    Biochem Biophys Res Commun; 1978 Dec 14; 85(3):1067-73. PubMed ID: 216361
    [No Abstract] [Full Text] [Related]

  • 32. Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
    Jergil B, Lindbladh C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1984 Dec 14; 64(2):155-7. PubMed ID: 6203305
    [Abstract] [Full Text] [Related]

  • 33. Urine homovanillic acid and tissue dopa oxidase in patients with melanoma.
    Morgan LR, Lolley D, Maddox B, Samuels MS, Krementz ET.
    Cancer; 1974 Jun 14; 33(6):1601-6. PubMed ID: 4210061
    [No Abstract] [Full Text] [Related]

  • 34. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ, Oliver I, Sherbet GV.
    Eur J Cancer Clin Oncol; 1988 Dec 14; 24(12):1879-84. PubMed ID: 2851444
    [Abstract] [Full Text] [Related]

  • 35. Dopa oxidase activity and ceruloplasmin in the sera of hamsters with melanoma.
    Vachtenheim J, Pavel S, Duchon J.
    Neoplasma; 1981 Dec 14; 28(1):59-65. PubMed ID: 6792550
    [Abstract] [Full Text] [Related]

  • 36. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
    García-Borrón JC, Martinez JH, Arocas A, Solano F, Vicente V, Gómez S, Iborra JL, Lozano JA.
    Int J Biochem; 1985 Dec 14; 17(9):995-1002. PubMed ID: 3934011
    [Abstract] [Full Text] [Related]

  • 37. Psoriasis before and after methotrexate (MXT) treatment. 3. Localization of dopa oxidase.
    Ramadan AA, Amin AM, Ismail AA, Mohessien A, Meguid NA.
    Folia Morphol (Praha); 1984 Dec 14; 32(4):342-4. PubMed ID: 6440836
    [No Abstract] [Full Text] [Related]

  • 38. Stimulation of tyrosinase activity of cultured melanoma cells by lysosomotropic agents.
    Saeki H, Oikawa A.
    J Cell Physiol; 1983 Jul 14; 116(1):93-7. PubMed ID: 6406524
    [Abstract] [Full Text] [Related]

  • 39. Hydroxylating activity of frog epidermis tyrosinase.
    García-Cánovas F, García-Carmona F, Galindo JD, Pedreño E, Lozano JA.
    Rev Esp Fisiol; 1979 Jun 14; 35(2):209-13. PubMed ID: 113854
    [Abstract] [Full Text] [Related]

  • 40. [Ultrastructural studies of the occurrence of tyrosinase in transplantable amelanotic melanoma in Syrian hamster].
    Bomirski A, Wrzolkowa T.
    Przegl Dermatol; 1976 Jun 14; 63(1):11-8. PubMed ID: 815964
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.